263 related articles for article (PubMed ID: 30463513)
1. Integration of transcriptome and proteome profiles in glioblastoma: looking for the missing link.
Lemée JM; Clavreul A; Aubry M; Com E; de Tayrac M; Mosser J; Menei P
BMC Mol Biol; 2018 Nov; 19(1):13. PubMed ID: 30463513
[TBL] [Abstract][Full Text] [Related]
2. Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis.
Lemée JM; Clavreul A; Aubry M; Com E; de Tayrac M; Eliat PA; Henry C; Rousseau A; Mosser J; Menei P
J Neurooncol; 2015 Mar; 122(1):53-61. PubMed ID: 25559687
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of glioblastomas: what is the best brain control sample?
Lemée JM; Com E; Clavreul A; Avril T; Quillien V; de Tayrac M; Pineau C; Menei P
J Proteomics; 2013 Jun; 85():165-73. PubMed ID: 23651564
[TBL] [Abstract][Full Text] [Related]
4. Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature.
Syafruddin SE; Nazarie WFWM; Moidu NA; Soon BH; Mohtar MA
BMC Cancer; 2021 Jul; 21(1):850. PubMed ID: 34301218
[TBL] [Abstract][Full Text] [Related]
5. Proteogenomics of glioblastoma associates molecular patterns with survival.
Yanovich-Arad G; Ofek P; Yeini E; Mardamshina M; Danilevsky A; Shomron N; Grossman R; Satchi-Fainaro R; Geiger T
Cell Rep; 2021 Mar; 34(9):108787. PubMed ID: 33657365
[TBL] [Abstract][Full Text] [Related]
6. Quantitative proteomic Isotope-Coded Protein Label (ICPL) analysis reveals alteration of several functional processes in the glioblastoma.
Com E; Clavreul A; Lagarrigue M; Michalak S; Menei P; Pineau C
J Proteomics; 2012 Jul; 75(13):3898-913. PubMed ID: 22575386
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis of transcriptome and proteome profiles in primary and recurrent glioblastoma.
Zhang J; Wang G; Yan B; Yang G; Yang Q; Hu Y; Guo J; Zhao N; Wang L; Wang H
Proteomics Clin Appl; 2024 May; 18(3):e2200085. PubMed ID: 38037768
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.
Lemée JM; Clavreul A; Menei P
Neuro Oncol; 2015 Oct; 17(10):1322-32. PubMed ID: 26203067
[TBL] [Abstract][Full Text] [Related]
9. A full-body transcriptome and proteome resource for the European common carp.
Kolder IC; van der Plas-Duivesteijn SJ; Tan G; Wiegertjes GF; Forlenza M; Guler AT; Travin DY; Nakao M; Moritomo T; Irnazarow I; den Dunnen JT; Anvar SY; Jansen HJ; Dirks RP; Palmblad M; Lenhard B; Henkel CV; Spaink HP
BMC Genomics; 2016 Sep; 17(1):701. PubMed ID: 27590662
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes.
Patil V; Mahalingam K
Gene; 2019 Feb; 685():85-95. PubMed ID: 30401645
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic and Proteomic Data Integration and Two-Dimensional Molecular Maps with Regulatory and Functional Linkages: Application to Cell Proliferation and Invasion Networks in Glioblastoma.
Gupta MK; Jayaram S; Reddy DN; Polisetty RV; Sirdeshmukh R
J Proteome Res; 2015 Dec; 14(12):5017-27. PubMed ID: 26464075
[TBL] [Abstract][Full Text] [Related]
13. Evolutionary hallmarks of the human proteome: chasing the age and coregulation of protein-coding genes.
Lopes KP; Campos-Laborie FJ; Vialle RA; Ortega JM; De Las Rivas J
BMC Genomics; 2016 Oct; 17(Suppl 8):725. PubMed ID: 27801289
[TBL] [Abstract][Full Text] [Related]
14. Identification of two glioblastoma-associated stromal cell subtypes with different carcinogenic properties in histologically normal surgical margins.
Clavreul A; Etcheverry A; Tétaud C; Rousseau A; Avril T; Henry C; Mosser J; Menei P
J Neurooncol; 2015 Mar; 122(1):1-10. PubMed ID: 25503303
[TBL] [Abstract][Full Text] [Related]
15. [Development of barcode and proteome profiling of glioblastoma].
Naryzhnyĭ SN; Ronzhina NL; Maĭnskova MA; Beliakova NV; Pantina RA; Filatov MV
Biomed Khim; 2014; 60(3):308-21. PubMed ID: 25019393
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20.
Marucci G; Morandi L; Magrini E; Farnedi A; Franceschi E; Miglio R; Calò D; Pession A; Foschini MP; Eusebi V
Virchows Arch; 2008 Dec; 453(6):599-609. PubMed ID: 18953566
[TBL] [Abstract][Full Text] [Related]
17. Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival.
Tang W; Zhou M; Dorsey TH; Prieto DA; Wang XW; Ruppin E; Veenstra TD; Ambs S
Genome Med; 2018 Dec; 10(1):94. PubMed ID: 30501643
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific transcriptomics and proteomics of a filarial nematode and its Wolbachia endosymbiont.
Luck AN; Anderson KG; McClung CM; VerBerkmoes NC; Foster JM; Michalski ML; Slatko BE
BMC Genomics; 2015 Nov; 16():920. PubMed ID: 26559510
[TBL] [Abstract][Full Text] [Related]
19. Towards developing biomarkers for glioblastoma multiforme: a proteomics view.
Jayaram S; Gupta MK; Polisetty RV; Cho WC; Sirdeshmukh R
Expert Rev Proteomics; 2014 Oct; 11(5):621-39. PubMed ID: 25115191
[TBL] [Abstract][Full Text] [Related]
20. Integrated genomic analysis of survival outliers in glioblastoma.
Peng S; Dhruv H; Armstrong B; Salhia B; Legendre C; Kiefer J; Parks J; Virk S; Sloan AE; Ostrom QT; Barnholtz-Sloan JS; Tran NL; Berens ME
Neuro Oncol; 2017 Jun; 19(6):833-844. PubMed ID: 27932423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
